WallStSmart

DocGo Inc (DCGO)vsEncompass Health Corp (EHC)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Encompass Health Corp generates 1911% more annual revenue ($6.07B vs $301.71M). EHC leads profitability with a 10.0% profit margin vs -62.2%. EHC earns a higher WallStSmart Score of 75/100 (B+).

DCGO

Hold

36

out of 100

Grade: F

Growth: 3.3Profit: 2.0Value: 6.7Quality: 5.5
Piotroski: 3/9Altman Z: -1.24

EHC

Strong Buy

75

out of 100

Grade: B+

Growth: 8.0Profit: 7.5Value: 6.7Quality: 6.0
Piotroski: 6/9Altman Z: 2.12
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

DCGOUndervalued (+53.4%)

Margin of Safety

+53.4%

Fair Value

$1.56

Current Price

$0.49

$1.07 discount

UndervaluedFair: $1.56Overvalued
EHCSignificantly Overvalued (-57.0%)

Margin of Safety

-57.0%

Fair Value

$72.26

Current Price

$101.31

$29.05 premium

UndervaluedFair: $72.26Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

DCGO2 strengths · Avg: 9.5/10
Price/BookValuation
0.4x10/10

Reasonable price relative to book value

Debt/EquityHealth
0.229/10

Conservative balance sheet, low leverage

EHC4 strengths · Avg: 8.8/10
PEG RatioValuation
0.4110/10

Growing faster than its price suggests

Return on EquityProfitability
24.2%9/10

Every $100 of equity generates 24 in profit

P/E RatioValuation
17.5x8/10

Attractively priced relative to earnings

EPS GrowthGrowth
30.3%8/10

Earnings expanding 30.3% YoY

Areas to Watch

DCGO4 concerns · Avg: 2.5/10
Market CapQuality
$54.93M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Return on EquityProfitability
-141.9%2/10

ROE of -141.9% — below average capital efficiency

Revenue GrowthGrowth
-21.3%2/10

Revenue declined 21.3%

EHC1 concerns · Avg: 3.0/10
Debt/EquityHealth
1.113/10

Elevated debt levels

Comparative Analysis Report

WallStSmart Research

Bull Case : DCGO

The strongest argument for DCGO centers on Price/Book, Debt/Equity.

Bull Case : EHC

The strongest argument for EHC centers on PEG Ratio, Return on Equity, P/E Ratio. PEG of 0.41 suggests the stock is reasonably priced for its growth.

Bear Case : DCGO

The primary concerns for DCGO are Market Cap, Piotroski F-Score, Return on Equity.

Bear Case : EHC

The primary concerns for EHC are Debt/Equity.

Key Dynamics to Monitor

DCGO profiles as a turnaround stock while EHC is a value play — different risk/reward profiles.

DCGO carries more volatility with a beta of 1.00 — expect wider price swings.

EHC is growing revenue faster at 9.0% — sustainability is the question.

EHC generates stronger free cash flow (151M), providing more financial flexibility.

Bottom Line

EHC scores higher overall (75/100 vs 36/100). DCGO offers better value entry with a 53.4% margin of safety. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

DocGo Inc

HEALTHCARE · MEDICAL CARE FACILITIES · USA

DocGo Inc. is an innovative mobile healthcare service provider that enhances patient access and optimizes healthcare delivery through its advanced logistics and telehealth solutions. Specializing in urgent care, diagnostic testing, and health screenings, DocGo addresses critical healthcare needs across various settings while significantly improving patient experiences. With a commitment to innovation and expanding healthcare accessibility, the company stands out in the rapidly evolving healthtech sector, positioning itself as a compelling investment opportunity for institutional investors seeking both sustainable growth and positive social impact.

Visit Website →

Encompass Health Corp

HEALTHCARE · MEDICAL CARE FACILITIES · USA

Encompass Health Corporation offers in-home and post-acute health care services in the United States. The company is headquartered in Birmingham, Alabama.

Want to dig deeper into these stocks?